![Charmaine Gittleson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charmaine Gittleson
Vorsitzender bei
PERCHERON THERAPEUTICS LIMITED
Vermögen: 8 870 $ am 31.08.2026
Profil
Dr. Charmaine Gittleson, MD, is an Independent Non-Executive Director at Polynovo Ltd. and a Non-Executive Chairman at Percheron Therapeutics Ltd. She is on the Board of Directors at Imugene Ltd., Polynovo Ltd. and George Medicines Pty Ltd. Dr. Gittleson was previously employed as a Chairman by Patrys Ltd. and a Chief Medical Officer by CSL Ltd. She received her undergraduate degree from the University of the Witwatersrand.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.12.2024 | 2.464.000 ( 0,16 % ) | 8 870 $ | 31.08.2026 |
Aktive Positionen von Charmaine Gittleson
| Unternehmen | Position | Beginn |
|---|---|---|
| PERCHERON THERAPEUTICS LIMITED | Vorsitzender | - |
| POLYNOVO LIMITED | Direktor/Vorstandsmitglied | 01.04.2026 |
| IMUGENE LIMITED | Direktor/Vorstandsmitglied | 30.06.2026 |
Ehemalige bekannte Positionen von Charmaine Gittleson
| Unternehmen | Position | Ende |
|---|---|---|
| PATRYS LIMITED | Vorsitzender | 17.06.2025 |
| CSL LIMITED | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Charmaine Gittleson
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Patrys Ltd.
 Patrys Ltd. Pharmaceuticals: MajorHealth Technology Develops novel antibody technologies for hard-to-treat cancers | Health Technology |
Imugene Ltd.
 Imugene Ltd. BiotechnologyHealth Technology Operates as a a clinical stage immuno-oncology company | Health Technology |
Polynovo Ltd.
 Polynovo Ltd. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
University of the Witwatersrand
 University of the Witwatersrand Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
